Portfolio 1
| Date | Name | Website | Total Raised | Location |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 20
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 4, 2024 | Boston Scientific to acquire Cortex and its cardiac mapping tech | Boston Scientific (NYSE: BSX) announced today that it will purchase Ajax Health’s Cortex and its FDA-cleared OptiMap system to guide physicians performing ablation procedures to treat AFib Financial terms of the deal were not disclosed. Bos... |
| May 15, 2024 | Cortex Announces Appointment of Dr. Matthew Lungren, Chief Data Science Officer for Microsoft Health & Life Sciences, to its Board of Directors | Dr. Lungren brings expertise translating cutting-edge AI technology into valuable healthcare applications MENLO PARK, Calif., May 15, 2024 /PRNewswire/ -- Cortex, a medical technology company aiming to transform the diagnosis and treatment ... |
| May 24, 2021 | AcuityMD Nabs $7M for Targeting Platform for Medical Device Companies | What You Should Know: – AcuityMD, a platform for commercializing and improving medical devices with data announced it has raised $7M in funding led by Benchmark with participation from Ajax Health. Eric Vishria, General Partner at Benchmark... |
| Mar 12, 2021 | Cardinal Health : signs definitive agreement to sell its Cordis business to Hellman & Friedman | DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes ... |
| Mar 12, 2021 | Cardinal Health signs definitive agreement to sell its Cordis business to Hellman & Friedman USA - English USA - English | |
| Mar 12, 2021 | Cardinal Health Signs Definitive Agreement to Sell its Cordis Business to Hellman & Friedman | March 12th, 2021 DUBLIN, Ohio Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes buyer’s assum... |
| Mar 12, 2021 | CARDINAL HEALTH, INC. Cardinal Health : signs definitive agreement to sell its Cordis business to Hellman & Friedman | DUBLIN, Ohio, March 12, 2021 /PRNewswire/ -- Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cordis business to Hellman & Friedman (H&F) for approximately $1 billion, which includes ... |
| Sep 30, 2019 | Ajax Health Closes Third $100M MedTech Innovation Fund | Duke Rohlen, Chairman and CEO, Ajax Health – Ajax Health raises $100M to close third medtech innovation, Ajax3 led by HealthQuest Capital with participation from Polaris Partners. – Led by Duke Rohlen, Chairman and CEO, Ajax3 quickly follow... |
| Sep 30, 2019 | Ajax Health raises $100 million to invest in MedTech startups developing disruptive technologies in the healthcare space | Ajax Health announced today that it has raised $100 million to form Ajax 3. The new capital will target investing in companies in the areas of medtech, healthcare services, and healthcare IT that focus on truly innovative approaches to addr... |
Reviews 0
FAQ about Ajax Health
How many startups has Ajax Health invested in?
Ajax Health has 1 portfolio company on Parsers VC.
What has the press written about Ajax Health?
Parsers VC has collected 20 articles mentioning Ajax Health, among them “Boston Scientific to acquire Cortex and its cardiac mapping tech” (Nov 4, 2024) and “Cortex Announces Appointment of Dr. Matthew Lungren, Chief Data Science Officer for Microsoft Health & Life Sciences, to its Board of Directors” (May 15, 2024).
Is Ajax Health still active?
Yes, Ajax Health is active; its latest activity on Parsers VC dates from May 14, 2026.